GENELINK INC. (GNLK) SELECTED AS "STOCK PICK OF THE MONTH" BY ANALYST LAWRENCE OAKLEY - CONSERVATIVE SPECULATOR
October 9, 2001

MARGATE, NJ - (Business Wire) - October 9, 2001 - GeneLink BioSciences, Inc. announced today that it has recently been selected as stock pick of the month by financial analyst Lawrence Oakley and is designated as "SITUATION OF THE MONTH" in the October 2001 Issue of Conservative Speculator. An excerpt of Oakley's report may be viewed on GeneLink's web site: www.genelink.info.

The entire Conservative Speculator report can be found on the web site:wallstreetcorner.com Please us the password 2001, and then click on October, 2001 Issue, which is displayed under the Conservative Speculator logo.

Oakley reports, "The GeneLink DNA Collection Kit' now offers the public a safe, easy, non-invasive method of collecting one's DNA and storing it confidentially at the Company's DNA Bank located in Fort Worth at the University of North Texas Health Science Center. The GeneLink system provides a simple, secure and cost-effective way to preserve an individual's or family's genetic history."

"For the first time, simply by swabbing the inside of one's mouth and sending the collected sample to GNLK's laboratories, a person can have a skin or personal care formulation specifically designed to compensate for associated deficiencies."

"GNLK is currently negotiating marketing agreements with some of the world's largest distributors of nutritional, skin-care, personal care, wellness, and anti-aging products. Revenues from the genetic profiling systems and ongoing royalties from product sales are expected to begin in Q1 2002." 

"On 9/19/2001, GNLK and Arch Personal Care Products L.P. of South Plainfield, NJ, a unit of Arch Chemicals, Inc. (NYSE/ARJ) announced they have entered into a collaborative agreement to create an innovative category of products for the personal care and cosmetics industry."

"I see GNLK's association with Arch as the first of many. I suspect the next one will be with a large nutritional supplement corporation. I think the strategy is brilliant. GNLK can take advantage of the huge sales forces of large companies. GNLK will get a small portion of the selling price of the products sold as a result of its technology being used. The revenue potential to GNLK could be staggering. I suggest you seriously look into this one. It's greatly undervalued in my opinion." 

And finally, "I recommend GNLK for both midterm and long-term appreciation." 

About GeneLink, Inc: GNLK is positioned to become a leading provider of genetic profiling technologies. It has developed a proprietary method for "genetic profiling" (patents pending) and will begin licensing this breakthrough technology to companies that market or manufacture products for the $100 billion plus nutraceutical, skin care, wellness and weight-loss industries. GNLK has recently received U.S patent number 6, 291,171 for its non-invasive DNA Collection Kit® Its DNA bank is located at the University of North Texas Health Science Center at Fort Worth, a 105-year-old medical facility that guarantees the DNA storage. 

Forward-Looking Statements: This news release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a new "safe harbor" for these types of statements.

SOURCE: GeneLink BioSciences, Inc.